525: Elexacaftor/tezacaftor/ivacaftor therapy alters the CF lung mucus metabolome, reshaping microbiome niche space
| Autor: | Quinn, R., Sosinski, L., Neugebauer, K., Ghuneim, L., Guzior, D., Castillo-Bahena, A., Mielke, J., McClelland, M., Thomas, R., Conrad, D. |
|---|---|
| Zdroj: | In Journal of Cystic Fibrosis November 2021 20 Supplement 2:S248-S248 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect